Myodesopsia International: Clinical Perspectives feat J. Sebag, MD, FACS, FRCOphth, FARVO

Описание: In this episode of Clinical Perspectives, Myodesopsia International speaks with J. Sebag, MD, FACS, FRCOphth, FARVO, renowned expert and a leading researcher in the ophthalmological study of the vitreous body. Dr Sebag discusses Vision Degrading Myodesopsia from Vitreous Floaters (VDM), the source of the condition, quantitative processes for diagnosis and evaluation, current treatments available (including limited refractive vitrectomy and YAG laser vitreolysis), future innovations in diagnosis and treatment, and the importance of patient advocacy groups to help create systemic change.

Myodesopsia International is working to create a world where chronic vitreous floaters are recognised, understood, and easily treated. Through conversations with doctors, technologists, researchers, and patients, we hope to build a deeper understanding of the condition and foster collaboration that expedites safe, effective, and accessible treatment options for those who are afflicted.

Additional links:

Vitreous Floaters Functional Questionnaire ©
JAMA Ophthalmol 143(11):925-931, 2025 - https://doi.org/10.1001/jamaophthalmo...
Am J Ophthalmol 2026 - https://doi.org/10.1016/j.ajo.2026.02...

VMR Institute: https://www.VMRinstitute.com

Myodesopsia International: https://www.myodesopsiainternational.org

Chapters
00:00 - Understanding Vision Degrading Myodesopsia (VDM)
03:42 - Diagnosing and Evaluating VDM
07:24 - Available Treatments for VDM
11:18 - Future Innovations and Industry Engagement
14:47 - The Importance of Patient-Led Organisations